ACTU Actuate Therapeutics, Inc.

Fundamentals / CIK 0001652935 / USD

Actuate Therapeutics, Inc. reported $3.22M in total assets and a net loss of $18.47M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open ACTU in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

3 fiscal years (2023 to 2025), reported in USD.

$0$0$0-$25.51MFY 2023 Net Income: -$24.74M2023FY 2024 Net Income: -$27.29M2024FY 2025 Net Income: -$22.23M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31
Research & Development $10.29M $18.68M $21.71M
Total Operating Expenses $22.50M $25.16M $24.97M
Operating Income -$22.50M -$25.16M -$24.97M
Interest Income $288K $222K $353K
Interest Expense $20K $19K $44K
Income Tax Expense $800 $800 $0
Net Income -$22.23M -$27.29M -$24.74M
Basic EPS -$1.06 -$3.26 -$17.24
Diluted EPS -$1.06 -$3.26 -$17.24
Basic Shares Outstanding 21.0M 8.4M 1.4M
Diluted Shares Outstanding 21.0M 8.4M 1.4M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Research & Development $1.81M $2.07M $2.57M $2.13M $2.18M $2.76M $3.22M $3.69M
Total Operating Expenses $3.44M $4.91M $5.71M $4.69M $5.47M $5.97M $6.37M $6.56M
Operating Income -$3.44M -$4.91M -$5.71M -$4.69M -$5.47M -$5.97M -$6.37M -$6.56M
Interest Income -- $45K $85K $140K $70K $25K $54K $118K
Interest Expense $5.1K $5.1K $5.1K $5.1K $5.1K $5.1K $5.1K $5.1K
Net Income -$3.42M -$4.87M -$5.63M -$4.55M -$5.41M -$5.95M -$6.32M -$6.45M
Basic EPS -$0.14 -$0.20 -$0.24 -- -$0.25 -$0.30 -$0.32 --
Diluted EPS -$0.14 -$0.20 -$0.24 -- -$0.25 -$0.30 -$0.32 --
Basic Shares Outstanding 24.2M 23.9M 23.5M -- 21.4M 19.6M 19.5M --
Diluted Shares Outstanding 24.2M 23.9M 23.5M -- 21.4M 19.6M 19.5M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $13.16M $8.64M --
Cash & Short-Term Investments $13.16M $8.64M --
Total Current Assets $13.64M $9.21M $3.00M
Other Non-Current Assets $392K $111K $0
Total Non-Current Assets $392K $111K $0
Total Assets $14.04M $9.32M $3.00M
Accounts Payable $1.52M $1.92M $3.42M
Total Current Liabilities $5.71M $8.80M $6.92M
Total Non-Current Liabilities $405K $412K $1.52M
Total Liabilities $6.11M $9.21M $8.44M
Common Stock $23 $20 $2
Retained Earnings -$154.6M -$132.4M -$105.1M
Total Stockholders' Equity $7.92M $104K -$99.63M
Total Equity $7.92M $104K -$99.63M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $2.10M $4.43M $8.13M $13.16M $16.92M $6.49M $3.89M $8.64M
Cash & Short-Term Investments $2.10M $4.43M $8.13M $13.16M $16.92M $6.49M $3.89M $8.64M
Total Current Assets $2.65M $4.75M $8.52M $13.64M $17.44M $6.69M $4.25M $9.21M
Other Non-Current Assets $571K $451K $392K $392K $270K $280K $234K $111K
Total Non-Current Assets $571K $451K $392K $392K $270K $280K $234K $111K
Total Assets $3.22M $5.20M $8.91M $14.04M $17.71M $6.97M $4.48M $9.32M
Accounts Payable $891K $1.08M $1.20M $1.52M $1.25M $3.17M $2.64M $1.92M
Total Current Liabilities $3.62M $3.81M $4.72M $5.71M $6.37M $9.20M $9.15M $8.80M
Total Non-Current Liabilities $405K $405K $405K $405K $405K $422K $417K $412K
Total Liabilities $4.03M $4.21M $5.13M $6.11M $6.78M $9.62M $9.57M $9.21M
Common Stock $25 $24 $24 $23 $23 $20 $20 $20
Retained Earnings -$168.5M -$165.1M -$160.2M -$154.6M -$150.1M -$144.6M -$138.7M -$132.4M
Total Stockholders' Equity -$809K $989K $3.78M $7.92M $10.94M -$2.65M -$5.09M $104K
Total Equity -$809K $989K $3.78M $7.92M $10.94M -$2.65M -$5.09M $104K

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31
Net Income -$22.23M -$27.29M -$24.74M
Stock-Based Compensation $6.05M $2.00M $424K
Change in Payables -$513K -$1.50M $1.29M
Operating Cash Flow -$19.21M -$21.84M -$21.63M
Common Stock Issued $3.83M $0 --
Financing Cash Flow $23.72M $27.53M $4.13M
Net Change in Cash $4.52M $5.68M -$17.49M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$3.42M -$4.87M -$5.63M -$4.55M -$5.41M -$5.95M -$6.32M -$6.45M
Stock-Based Compensation $971K $1.34M $1.36M $1.54M $1.80M $1.58M $1.13M $1.19M
Change in Payables -$280K -$151K -$323K $186K -$1.83M $508K $622K -$303K
Operating Cash Flow -$2.95M -$4.41M -$5.02M -$3.74M -$6.68M -$4.17M -$4.62M -$4.77M
Common Stock Issued $774K $732K $520K $3.83M $0 $0 $0 --
Financing Cash Flow $627K $697K -$8.1K -$29K $17.11M $6.78M -$133K -$109K
Net Change in Cash -$2.32M -$3.71M -$5.03M -$3.77M $10.43M $2.60M -$4.75M -$4.88M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31
Return on Equity (ROE) -280.5% -26189.1% --
Return on Assets (ROA) -158.4% -292.8% -826.0%
Current Ratio 2.39x 1.05x 0.43x
Quick Ratio 2.31x 0.98x --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -- -2067.8% -569.1% -280.5% -220.6% -- -- -26189.1%
Return on Assets (ROA) -573.7% -393.4% -241.7% -158.4% -136.2% -354.2% -564.5% -292.8%
Current Ratio 0.73x 1.25x 1.80x 2.39x 2.74x 0.73x 0.46x 1.05x
Quick Ratio 0.58x 1.16x 1.72x 2.31x 2.66x 0.71x 0.42x 0.98x
Source: SEC EDGAR CompanyFacts (CIK 0001652935) · from March 31, 2023 Data through September 30, 2026 · synced Nov 21, 2026, 05:08 UTC · Open in terminal